Cancer treatment in the past decade has rapidly changed with the introduction of immune checkpoint inhibitors (ICIs). Myocarditis is a rare but potentially deadly complication of ICI treatment. We aim… Click to show full abstract
Cancer treatment in the past decade has rapidly changed with the introduction of immune checkpoint inhibitors (ICIs). Myocarditis is a rare but potentially deadly complication of ICI treatment. We aim to describe presentation and long-term outcomes of ICI related myocarditis in comparison to a
               
Click one of the above tabs to view related content.